ResearcherShizuoka Cancer CenterNo recent work listed
Hirofumi Yasui
Matched on ORCID iD 0000-0002-7176-8354; OpenAlex author ID A5101921121. Sources: OpenAlex.
Their work
- Papers
- 4 (first author 0, last author 1)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 14
2017: 1 paper · 2018: none · 2019: none · 2020: none · 2021: none · 2022: 1 paper · 2023: 2 papers
Papers 4
- Genetic medicine in companion diagnostics of germline BRCA testing of Japanese pancreatic cancer patients. Co-author DOI 10.1038/s10038-022-01097-y↗
- Biomarker analysis for patients with pancreatic cancer treated with nanoliposomal irinotecan plus 5-fluorouracil/leucovorin. Co-author DOI 10.1186/s12885-023-10542-w↗
- Effectiveness and safety of gemcitabine plus nab-paclitaxel in elderly patients with advanced pancreatic cancer: a single-center retrospective cohort study. Co-author DOI 10.1007/s10637-022-01221-x↗
- Gastrojejunostomy versus duodenal stent placement for gastric outlet obstruction in patients with unresectable pancreatic cancer. Last author DOI 10.1016/j.pan.2017.09.011↗
Closest collaborators
The 14 strongest of 14 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Kentaro Yamazaki · 4 shared papers, 2017–2023 · strength 0.53
- Paper Biomarker analysis for patients with pancreatic cancer treated with nanoliposomal irinotecan plus 5-fluorouracil/leucov… DOI 10.1186/s12885-023-10542-w↗
- Paper Effectiveness and safety of gemcitabine plus nab-paclitaxel in elderly patients with advanced pancreatic cancer: a sing… DOI 10.1007/s10637-022-01221-x↗
- Paper Genetic medicine in companion diagnostics of germline BRCA testing of Japanese pancreatic cancer patients. DOI 10.1038/s10038-022-01097-y↗
- Akiko Todaka · 4 shared papers, 2017–2023 · strength 0.53
- Paper Biomarker analysis for patients with pancreatic cancer treated with nanoliposomal irinotecan plus 5-fluorouracil/leucov… DOI 10.1186/s12885-023-10542-w↗
- Paper Effectiveness and safety of gemcitabine plus nab-paclitaxel in elderly patients with advanced pancreatic cancer: a sing… DOI 10.1007/s10637-022-01221-x↗
- Paper Genetic medicine in companion diagnostics of germline BRCA testing of Japanese pancreatic cancer patients. DOI 10.1038/s10038-022-01097-y↗
- Takeshi Kawakami · 3 shared papers, 2022–2023 · strength 0.47
- Paper Biomarker analysis for patients with pancreatic cancer treated with nanoliposomal irinotecan plus 5-fluorouracil/leucov… DOI 10.1186/s12885-023-10542-w↗
- Paper Effectiveness and safety of gemcitabine plus nab-paclitaxel in elderly patients with advanced pancreatic cancer: a sing… DOI 10.1007/s10637-022-01221-x↗
- Paper Genetic medicine in companion diagnostics of germline BRCA testing of Japanese pancreatic cancer patients. DOI 10.1038/s10038-022-01097-y↗
- Teiichi Sugiura · 2 shared papers, 2017–2023 · strength 0.20
- Paper Genetic medicine in companion diagnostics of germline BRCA testing of Japanese pancreatic cancer patients. DOI 10.1038/s10038-022-01097-y↗
- Paper Gastrojejunostomy versus duodenal stent placement for gastric outlet obstruction in patients with unresectable pancreat… DOI 10.1016/j.pan.2017.09.011↗
- Sae Ohwada · 1 shared paper, 2022 · strength 0.15
- Hiromichi Shirasu · 1 shared paper, 2022 · strength 0.15
- Hiroshi Nakase · 1 shared paper, 2022 · strength 0.15
- Yoshimi Kiyozumi · 1 shared paper, 2023 · strength 0.14
- Fumitaka Niiya · 1 shared paper, 2023 · strength 0.14
- Hirotoshi Ishiwatari · 1 shared paper, 2023 · strength 0.14
- Hiroyuki Matsubayashi Md · 1 shared paper, 2023 · strength 0.14
- Hiroyuki Ono · 1 shared paper, 2023 · strength 0.14
- Akira Fukutomi · 1 shared paper, 2017 · strength 0.06
- Yukio Yoshida · 1 shared paper, 2017 · strength 0.06
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.